These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27320459)

  • 41. Stroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia.
    Jeste ND; Sánchez LM; Urcuyo GS; Bergés ME; Luden JP; Stuber SE; Latham TS; Mena R; Nieves RM; Ware RE
    JMIR Res Protoc; 2017 Jun; 6(6):e107. PubMed ID: 28576754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease.
    Buchanan ID; James-Herry A; Osunkwo I
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):543-6. PubMed ID: 23211694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Screening of cerebral vasculopathy in sickle cell anemia children using transcranial Doppler].
    Dorie A; Guindo A; Saro YS; Touré BA; Fané B; Dembelé AK; Diallo DA
    Arch Pediatr; 2015 Mar; 22(3):260-6. PubMed ID: 25636211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcranial Doppler screening for stroke risk in children with sickle cell disease: a systematic review.
    Mazzucco S; Diomedi M; Qureshi A; Sainati L; Padayachee ST
    Int J Stroke; 2017 Aug; 12(6):580-588. PubMed ID: 28440126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).
    Galadanci NA; Umar Abdullahi S; Vance LD; Musa Tabari A; Ali S; Belonwu R; Salihu A; Amal Galadanci A; Wudil Jibir B; Bello-Manga H; Neville K; Kirkham FJ; Shyr Y; Phillips S; Covert BV; Kassim AA; Jordan LC; Aliyu MH; DeBaun MR
    Am J Hematol; 2017 Aug; 92(8):780-788. PubMed ID: 28439953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcranial doppler re-screening of subjects who participated in STOP and STOP II.
    Adams RJ; Lackland DT; Brown L; Brown D; Voeks J; Fullerton HJ; Kanter J; Kwiatkowski JL
    Am J Hematol; 2016 Dec; 91(12):1191-1194. PubMed ID: 27623561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcranial Doppler ultrasonography in sickle cell disease: a study in Omani patients.
    Gujjar AR; Zacharia M; Al-Kindi S; William R; Al Lamki Z; Wali Y; Bashir W; Jain R; Al-Asmi A; Pathare A
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):18-23. PubMed ID: 23249960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Normalized transcranial Doppler velocities, stroke prevention and improved pulmonary function after stem cell transplantation in children with sickle cell anemia.
    Mynarek M; Bettoni da Cunha Riehm C; Brinkmann F; Weißenborn K; Tell-Lüersen M; Heuft HG; Maecker-Kolhoff B; Sykora KW
    Klin Padiatr; 2013 May; 225(3):127-32. PubMed ID: 23625683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcranial Doppler scanning and the assessment of stroke risk in children with HbSC [corrected] disease.
    Deane CR; Goss D; O'Driscoll S; Mellor S; Pohl KR; Dick MC; Height SE; Rees DC
    Arch Dis Child; 2008 Feb; 93(2):138-41. PubMed ID: 17925326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TCD methodology in children with sickle-cell anemia.
    Razumovsky AY
    Pediatr Radiol; 2002 Sep; 32(9):690-1; author reply 692-3. PubMed ID: 12422847
    [No Abstract]   [Full Text] [Related]  

  • 51. Transcranial Doppler, MRA, and MRI as a screening examination for cerebrovascular disease in patients with sickle cell anemia: an 8-year study.
    Seibert JJ; Glasier CM; Kirby RS; Allison JW; James CA; Becton DL; Kinder DL; Cox KS; Flick EL; Lairry F; Jackson JF; Graves RA
    Pediatr Radiol; 1998 Mar; 28(3):138-42. PubMed ID: 9561529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.
    Galadanci NA; Abdullahi SU; Tabari MA; Abubakar S; Belonwu R; Salihu A; Neville K; Kirkham F; Inusa B; Shyr Y; Phillips S; Kassim AA; Jordan LC; Aliyu MH; Covert BV; DeBaun MR
    Pediatr Blood Cancer; 2015 Mar; 62(3):395-401. PubMed ID: 25399822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler.
    Bernaudin F; Verlhac S; Coïc L; Lesprit E; Brugières P; Reinert P
    Pediatr Radiol; 2005 Mar; 35(3):242-8. PubMed ID: 15703901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Problems with implementing a standardised transcranial Doppler screening programme: impact of instrumentation variation on STOP classification.
    Padayachee ST; Thomas N; Arnold AJ; Inusa B
    Pediatr Radiol; 2012 Apr; 42(4):470-4. PubMed ID: 22002844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease.
    Enninful-Eghan H; Moore RH; Ichord R; Smith-Whitley K; Kwiatkowski JL
    J Pediatr; 2010 Sep; 157(3):479-84. PubMed ID: 20434165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reticulocyte count is the most important predictor of acute cerebral ischemia and high-risk transcranial Doppler in a newborn cohort of 395 children with sickle cell anemia.
    Belisário AR; Sales RR; Toledo NE; Muniz MB; Velloso-Rodrigues C; Silva CM; Viana MB
    Ann Hematol; 2016 Oct; 95(11):1869-80. PubMed ID: 27520094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Will submandibular TCD prevent stroke in children with sickle cell anemia?
    Jordan LC; Strouse JJ
    Neurology; 2009 Aug; 73(5):340-1. PubMed ID: 19553590
    [No Abstract]   [Full Text] [Related]  

  • 58. Burden of neurological and neurocognitive impairment in pediatric sickle cell anemia in Uganda (BRAIN SAFE): a cross-sectional study.
    Green NS; Munube D; Bangirana P; Buluma LR; Kebirungi B; Opoka R; Mupere E; Kasirye P; Kiguli S; Birabwa A; Kawooya MS; Lubowa SK; Sekibira R; Kayongo E; Hume H; Elkind M; Peng W; Li G; Rosano C; LaRussa P; Minja FJ; Boehme A; Idro R
    BMC Pediatr; 2019 Oct; 19(1):381. PubMed ID: 31651270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in Transcranial Doppler Flow Velocities in Children with Sickle Cell Disease: The Impact of Hydroxyurea Therapy.
    Adegoke SA; Macedo-Campos RS; Braga JAP; Figueiredo MS; Silva GS
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):425-431. PubMed ID: 29056404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results.
    Lee MT; Piomelli S; Granger S; Miller ST; Harkness S; Brambilla DJ; Adams RJ;
    Blood; 2006 Aug; 108(3):847-52. PubMed ID: 16861341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.